Dawn Lobban, PhD, Envision Pharma Group, Wilmslow, UK; Jacqui Oliver, PhD, Envision Pharma Group, Wilmslow, UK; Alexandra Freeman, DPhil, University of Cambridge, UK; Simon Stones, BSc (Hons), Envision Pharma Group, Wilmslow, UK; Abbie Pound, BSc/BA, Ipsen, Slough, UK...
Medical publication policies and guidelines offer a framework for best practices, but there may be situations when more than one approach seems reasonable. The primary purpose of “What Would You Do?” is to explore examples of such situations. With the limited...
Learn from the scientific posters presented at the 2021 European Meeting of ISMPP in January and the 17th Annual Meeting of ISMPP in April. Thank you to the ISMPP members who presented posters/oral presentations this year! Find out about the first US Food and Drug...
In what has been a unique year with facing the COVID-19 pandemic, changing practices for medical publications and communications, and adjusting to work from home and virtual congresses, ISMPP was especially thrilled to have over 650 attendees participate in our...
Michelle Kissner, PharmD, Pfizer Inc, New York, NY; Devy Lee, BSc (Pharm), ISMPP CMPP™, Pfizer Inc, Lake Forest, IL This article shares information about Pfizer’s experience with the need to develop guidelines and adjust processes, given the impact of the COVID-19...
